In rodents, semaglutide has been linked to an increased risk of thyroid C-cell tumors. It’s not clear if semaglutide also increases the risk of thyroid cancer in humans. It may be a good idea to avoid ...

Semaglutide injections effectively support weight loss by regulating appetite and glucose levels, offering benefits for ...

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, ...

More Tennessee companies are covering weight-loss injections in health care benefit plans. This could impact the state's high ...

Researchers in France have developed a once-a-month hydrogel-based delivery system for semaglutide, significantly simplifying ...

People taking semaglutide for type 2 diabetes and/or weight control could have to take the medication just once a month, thanks to development of a monthly shot that contains a hydrogel.

Data from an early stage clinical trial suggests Novo Nordisk’s new weight loss pill amycretin could produce greater and more ...

Weight reduction at one year linked to medication active agent, dosage, treatment indication, persistence of coverage ...

Obesity is among the world’s most common health conditions, but for years medicine had few effective approaches to offer ...

The success of weight-loss injections has prompted pharmaceutical companies to produce a next-generation anti-obesity pill ...

Orforglipron has the potential to become the first oral glucagon-like peptide-1 receptor (GLP-1R) agonist to reach the ...

New weight loss drugs promise to reduce the 650 deaths and 12,000 hospitalisations a year in Hunter-New England from people ...